Labège, France

Antabio Sas

Calculating rank
USPTO Granted Patents = 7


Forward Citations = 2

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal David Thomas Davies (7 out of 7 patents)

silverMedal Simon Leiris (6 out of 6 patents)

bronzeMedal Nicolas Sprynski (4 out of 4 patents)

4.  Martin Everett (4 out of 4 patents)

5.  Thomas David Pallin (4 out of 30 patents)

6.  Andrew Peter Cridland (3 out of 3 patents)

7.  Lilha Beyria (3 out of 3 patents)

8.  David Edward Clark (3 out of 26 patents)

9.  Richard Leonard Elliott (3 out of 16 patents)

10.  Toby Jonathan Blench (3 out of 11 patents)

11.  Jonathan Mark Sutton (1 out of 33 patents)

12.  Magdalena Zalacain (1 out of 45 patents)

13.  Michael Steven Bodnarchuk (1 out of 1 patent)

14.  Marc Lemonnier (1 out of 1 patent)

15.  David Pallin (0 patent)


7 patents:

Company Overview
Antabio is a biopharmaceutical company focused on the development of novel antibacterial treatments. The company's innovative approach targets drug-resistant bacterial infections, providing new treatment options for patients. Antabio's pipeline includes promising candidates for multiple indications, with a strong emphasis on addressing the global health threat of antibiotic resistance.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

7 Patents

#4 in Labège

#2,225 in France

Labège, FR
Labège, France
Forward Citations = 2

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Antabio Sas. Retrieved from https://idiyas.com/company/antabio-sas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…